| 1. |
Lipoprotein (a) - independent risk factor |
| |
Inpharma Weekly,
Volume &NA;,
Issue 938,
1994,
Page 2-2
&NA;,
Preview
|
PDF (796KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
| 2. |
Dual therapy in GI diseasewhen should it be used and by who? |
| |
Inpharma Weekly,
Volume &NA;,
Issue 938,
1994,
Page 3-4
Robert Short,
Preview
|
PDF (1549KB)
|
|
摘要:
Eradication therapies forHelicobacter pyloriusing a proton pump inhibitor and an antibacterial are beginning to challenge the notoriously unpleasant and complicated triple therapy regimens (bismuth chelate, metronidazole, and either tetracycline or amoxicillin). Dual therapy appears to be more convenient to use, with fewer adverse effects. Accordingly, clinicians are likely to be more receptive to its use in their patients. This situation brings with it an urgent need for clarification of the appropriate role of eradication treatments.
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
| 3. |
Views in the news- A weekly update on bottom-line conclusions and recommendations from the literature - |
| |
Inpharma Weekly,
Volume &NA;,
Issue 938,
1994,
Page 4-4
&NA;,
Preview
|
PDF (809KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
| 4. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 938,
1994,
Page 5-5
&NA;,
Preview
|
PDF (770KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
| 5. |
Views in the news- A weekly update on bottom-line conclusions and recommendations from the literature - |
| |
Inpharma Weekly,
Volume &NA;,
Issue 938,
1994,
Page 6-6
&NA;,
Preview
|
PDF (790KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
| 6. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 938,
1994,
Page 7-7
&NA;,
Preview
|
PDF (786KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
| 7. |
G-CSFeffective but expensive |
| |
Inpharma Weekly,
Volume &NA;,
Issue 938,
1994,
Page 8-8
&NA;,
Preview
|
PDF (715KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
| 8. |
Total malaria eradication - are we any closer? |
| |
Inpharma Weekly,
Volume &NA;,
Issue 938,
1994,
Page 9-10
Lori Bonertz,
Preview
|
PDF (1520KB)
|
|
摘要:
The goal of eradicating malaria, set in the 1950s, has still not been achieved today. But are we any closer? Estimates of the number of clinical cases of malaria range from 300-500 million each year and the infection is expected to be fatal in over 1 million people, the majority of them children. Although this sounds discouraging, there is hope that new methods of both prevention and cure will impact on the disease. The prophylactic Spf66 vaccine is proving highly immunogenic in current trials, and the research drug arteflene may provide another option for quinine-resistant malaria. The latest research was discussed at the 6th International Congress of Infectious Diseases [Prague, Czech Republic; April 1994].
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
| 9. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 938,
1994,
Page 10-10
&NA;,
Preview
|
PDF (742KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
| 10. |
A‘refreshingly different approach’using monoclonal antibodies |
| |
Inpharma Weekly,
Volume &NA;,
Issue 938,
1994,
Page 11-11
&NA;,
Preview
|
PDF (764KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
首页
